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SUMMARY
A high incidence of resistance to trimethoprim has been shown in the normal
faecal flora in a population in south India. The dihydrofolate reductase (dhfr)
genes mediating transferable resistance to trimethoprim have been identified.
Unusually, in this study, the dhfrV was shown to be the predominant resistance
gene (dhfrV 50% of transconjugants, dhfrla 30%), the dhfrlb was also detected
being distinguished from the dhfrV by an oligo-probe. However, when non-
transferable resistance was considered, the dhfrIa was the most prevalent of the
dhfrs identified. All those plasmids harbouring the dhfrla were shown to possess
Tn7. All the plasmids that probed positive for the dhfrV and the dhfrlb were
shown to be associated with the integrase of the Tn2l-like transposons, but 8 of
the dhfrV genes were not associated with the Tn2l resolvase. The dhfrIV was
shown to be present in all seven plasmids that produced low level trimethoprim-
resistance. The dhfrV, first characterized in Sri Lanka, would seem to have a local
distribution in this region of Asia but is distinguishable from the dhfrlb only by
the use of an oligo-probe.
INTRODUCTION
Trimethoprim, a selective inhibitor of bacterial dihydrofolate reductase
(DHFR) Li], has been widely used throughout the world in the treatment of a
number of infections, for over 20 years, either alone or in combination with a
sulphonamide. Despite the emergence of resistance mediated by plasmid-encoded
DHFRs insensitive to the action of trimethoprim [2], resistance has remained at
relatively low levels in industrialized countries [3, 4]. In developing countries,
however, resistance is a growing problem, with high levels being reported in
Africa, South America and Asia amongst enterobacteria [5-7], including
Salmonella spp. [8, 9] and Shigella spp. [10-12]. High levels of resistance have also
been reported in the normal faecal flora from populations in Africa and Asia
[13-16] and in the Netherlands [17, 18].
Plasmid-encoded resistance to trimethoprim is mediated by DHFR enzymes
that are insensitive to inhibition by the drug. Sixteen such enzymes have been
identified in the Enterobacteriaceae [19, 20]. The nucleotide sequences of many of
* For correspondenee and reprint requests.
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these have been determined and the types Ia [21], lb [22], V [23], VI [24] and VII
[25] have been shown to be closely related. The DHFR type Ia is found associated
with the transposon Tn7, which integrates at a high frequency into the Escherichia
coli chromosome, at a specific site attTn7 [26]. As a result, the type Ia is the most
widespread and frequently isolated of the trimethoprim resistant DHFRs [4, 27]
and has been increasingly identified in the chromosomes of trimethoprim resistant
E. coli [28]. The type Ia has also been found, infrequently, in association with
Tn2l-like transposons [28, 29]. In this location it has become integrated at the
recombination site contained within the integron region of the Tn2l group of
transposons [29]. The type Ia is bounded by regions that are similar to integron
associated sequences; however, a functional integron is not present. Other
resistance genes are found at this site, perhaps indicating past integron activity
[30, 31].
The DHFR types Ia, IIc, V, VII and X have been found as gene-cassettes
located at the integron-associated active recombination locus of Tn2l-like
transposons [25, 32]. The DHFR lb has only been characterized as part of a Tn7-
like transposon [33]. Despite the location as part of such a promiscuous group of
transposons, the DHFR types V, VI, VII and X are far less frequently identified
in trimethoprim resistant strains than the DHFR type Ia [3], and little is known
of the epidemiology of the dhfrlb [33]. The DHFR type IV, on the other hand, has
only ever been identified in plasmids isolated from urinary pathogens in this area
of India [34]. This DHFR confers only low level resistance, conferring an MIC of
4 mg/l as determined on IST agar [35]. It has, however, been shown to be
inducible, under certain circumstances, that results in a much higher MIC [36, 37].
In 1990, almost universal carriage of enterobacteria resistant to ampicillin,
chloramphenicol and trimethoprim was reported in south India [13] in the town
of Vellore and 3 rural villages near to this town. In this present study, the nature
of the resistance to trimethoprim in these strains is investigated and the genes
mediating this resistance are identified.
MATERIALS AND METHODS
'Breakpoint' sensitivity tests were performed at 10 mg/l of antibiotic [38], and
50 mg/l of HgCl2 [29], unless otherwise indicated. Minimum inhibitory concentra-
tions were determined by doubling dilution in Isosensitest agar (Oxoid,
Basingstoke, UK). Transfer of plasmids to the standard rifampicin resistant E. coli
J62-2 was by the method of Amyes and Gould [38]. Plasmid DNA from the
resulting transconjugants was prepared by the method of Takahashi and Nagano
[39]. Subsequent digestion with restriction endonucleases was carried out under
the conditions recommended by the manufacturers (Gibco BRL, Life Sciences,
Paisley, Scotland). Plasmid DNA was separated in a 0-6% agarose gel while
digests of plasmid DNA were separated in 0-8% agarose.
Plasmid DNA was transferred to Hybond C-Extra (Amersham, UK), by a
modified method of Southern [40], as recommended by the manufacturer. Colony
blotting was performed by the method described by Sundstrom and colleagues
[41]. The probes for the various dhfr genes, used to identify the trimethoprim
resistance mechanisms, and the transposon and integron open reading frames
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Table 1. Probes used in hybridization studies, and their origin
Probe for Derivation Probe fragment Reference
dhfrla pFE872 HpaJI 499 bp 21
dhfrIIa pFE700 EcoRI 800 bp 42
dhfr III pUN972 EcoRI, PstI,700 bp (Gift of K. J. Towner)
dhfrIV pUK1148 ClaJC1700bp 43
dhfrV pLK09 Hinc II 500 bp 43
dhfrVII pUN1056 EcoRV 300 bp 44
*tnpA of Tn2l pGS150 EcoRI 1-25 Kb 29
tIn Tn2l pRSSO0I1I Aval, Hpal 1-7 Kb 29
tIn Tn7 pLK026 BamHI, Kpn 1 K29 Kb 29
* Resolvase gene of Tn2l. tlntegrase-like orf of Tn2l. tIntegrase-like orf of Tn7.
(ORFs), are as outlined in Table 1. The vectors carrying these various probes were
prepared by the polyethylene glycol method described by Sambrook, Fritsch and
Maniatis [45]. The probe fragments were isolated with the Geneclean (BiolOl, La
Jolla, CA) DNA preparation kit. The probes were labelled with biotin by nick
translation (Gibco BRL, Life Sciences, Paisley, Scotland) for the preparation of
probes for hybridization with plasmid blots or with dCTP[32P] (Amersham, UK)
by the random prime method (Gibco BRL, Life Sciences, Paisley, Scotland)
colony hybridization.
An oligo-nucleotide probe, as characterized by Young and colleagues was used
to distinguish the dhfrlb in those plasmids that hybridized with the dhfrV gene
probe. This has shown to be necessary to differentiate between these two dhfr
genes because of sequence homology [33]. The probe was labelled and detected by
the ECL kit (Amersham, UK) following the manufacturer's instructions.
Hybridization wash and detection conditions for biotinylated probes, for high
stringency, were as described by the manufacturer (Gibco BRL, Life Sciences,
Paisley, Scotland). Colony blots were hybridized and washed under conditions of
high stringency as described by Sundstrom and colleagues [41].
RESULTS
Resistance in wild-type strains
One hundred and four trimethoprim resistant strains were tested for resistance
to other antimicrobial agents and the MIC of trimethoprim was determined in
both wild-type and transconjugant strains. Rates of resistance to those
antimicrobials tested are outlined in Figure 1. In total, 62 isolates were resistant
to 6 or more of the agents tested. No resistance was encountered to cefotaxime
(1 mg/l), ceftazidime (2 mg/l), cefuroxime (4 mg/l), gentamicin (1 mg/l), or
ciprofloxacin (0 1 mg/l) in any of the organisms tested. All but 8 of the wild-type
strains had MICs of > 1024 mg/l for trimethoprim.
Plasmid-mediated resistance
Thirty-six of the 104 trimethoprim resistant strains were capable of transferring
this resistance to E. coli K12 J62-2. All of these donors were identified as E. coli
by the API 20E system. The antibiotic resistance profiles of the transconjugants
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Fig. 1. Number of isolates resistant to other antimicrobial agents in the trimethoprim
resistant strains. Tp, trimethoprim; Tc, tetracycline; Ap, ampicillin; Su, sulpha-
methoxazole; Sm, streptomycin; Sp, spectinomvcin; Cm. chloramphenicol; HgCI2.
mercuric chloride; Km, kanamycin; Cp. cephaloridine.
Table 2. Resistance profiles of the trimethoprim resistant transconjugants
Resistance profile*
Tp
Tp Tc
Tp Ap
Tp Su Sm
Tp(L) Su Sm
Tp Tc Cm Hg
Tp Tc Cm Hg Ap
Tp Tc Cm Ap
Tp Su Tc Sm
Tp Su Tc Sm Ap
Tp(L) Su Tc Sm Ap
Tp(L) Su Sm Ap Km
Tp Tc Ap Sp Sm Km
Tp Su Tc Sm Ap
Tp Su Ap Sm Sp
Tp Su Tc Ap Sm Sp
Tp Su Tc Cm Sm Ap Km C(p Hg Ag
Transconjugant strain number
13, 91, 147, 185
188
166
7, 32
179
64
160
111
190
199
10. 16, 34, 35. 36
118
163
20. 120, 198
217
6, 26, 29. 167, 208, 219
186, 2, 9. 60
* L indicates low level resistance to trimethoprim Ag, amoxicillin/clavulanic acid.
are shown in Table 2. Twenty-nine of these 36 transconjugants demonstrated high
level resistance to trimethoprim with MICs at or above 512 mg/I. Seven of the
transconjugants demonstrated low level resistance to trimethoprim, the donor
strains of all 7 also had low MICs of trimethoprim, all with MICs between 4 and
64 mg/l.
Seventeen different antibiotic resistance profiles in the transconjugants were
found (Table 2). However, on restriction endonuclease digest analysis of the
plasmids prepared from the transconjugants, 27 quite distinct patterns could be
identified. Thus it appears that 27 different plasmids are responsible for
trimethoprim resistance, and a number of other resistance mechanisms, in this
population of Gram-negative rods from normal faecal samples.
250
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Table 3. Characteristics of plassmids positive for the dhfr V probe
Donor Resistance profile
13 Tp
91 Tp
147 Tp
192 Tp
166 Tp, Ap
7 Tp, Su, Sm
32 Tp, Su, Sm
64 Tp, Tc, Cm, Hg
190 Tp, Su, Tc, Sm
160 Tp, Tc, Cm, Ap, Hg
199 Tp, Su, Tc, Sm, Ap
20 Tp, Su, Tc, Sm, Ap
198 Tp, Su, Tc, Sm, Ap
Plasmid sizes (Kb)
69
46, 2
53, 13, 4
54, 8, 3
64, 13, 6
82
74, 17, 4, 2
80, 55
100, 8, 3
80, 46
82
120
52
Jnl* tnpA*
+_
+_
+_
+_
+_
+_
+
+
+
+
+
+
+ +
+ +
+ +
* In] is the probe for ORF of the putative integrase, tnpA is the probe for the resolvase of Tn21.
The largest plasmid carried the dhfr in all cases.
Table 4. Characteristics of plasmids positive for the dhfrIb oligo-probe
Resistance profile
Tp. Su, Tc, Sm, Ap
Tp. Su, Tc, Cm, Sm, Ap, Cp, Hg, Km, Ag
Tp, Su, Tc, Cm, Sm, Ap. Cp, Hg, Km, Ag
Tp, Su, Tc. Cm, Sm, Ap, Cp, Hg, Km, Ag
Tp, Su, Tc Cm, Sm, Ap, Cp, Hg, Km, Ag
Plasmid
sizes (Kb)
30
70, 63
89
100
108
Inl* tnpA*
+
+
+ +
+ +
* Inl is the probe for ORF of the putative integrase, tnpA is the probe for the resolvase of
Tn21. The largest plasmid carried the dhfr in all cases.
Hybridization with dhfr probes
When the transconjugants were hybridized with the various probes for the
trimethoprim resistant DHFRs, positive results were obtained with 3 of the
probes. None of the plasmids was negative for any of the probes tested, and none
hybridized with more than one gene probe.
Eighteen of the plasmids hybridized with the probe for the type V DHFR
(Table 3). However, 5 of these were subsequently shown to be dhfrlb genes when
the oligo-probe was used to distinguish between these 2 dhfr genes that showed
close sequence homology (Table 4). These plasmids were then tested for positive
hybridization with probes for the tnpA gene of Tn2l and the gene coding for the
integrase associated with the integron. All those plasmids harbouring the dhfrV
and dhfrlb gene also possessed the open reading frame (ORF) of the integrase.
However, 8 plasmids encoding the dhfrV did not possess the tnpA for the Tn2l
transposase. This suggests the absence of the Tn2l transposon in these plasmids
(Table 3).
Some of the plasmids, encoding the dhfrV gene, were shown to be very similar
when their restriction endonuclease digest patterns were compared. The plasmids
from strains 13, 91, 147 and 192 were shown to be very similar, although not
Donor
120
186
2
9
60
S. TAIT AND S. G. B. AMYES
Fig. 2. A 08'Vo agarose gel of a BaniHi restriction endonuclease digest of plasmids
isolated from the transconjugants 13, 91, 147 and 192, harbourinig the dhfrV' genie: A,
13: B. 91; C. 147; D. 192.
identical (Fig. 2), and were counted as one group. They were, however, isolated
from different sites, 1 each from 2 of the villages (13, 19) and 2 from the town of
V'ellore itself (147, 192). These plasmids also encoded only trimethoprim resistance
out of all the antimicrobials tested. The plasmids from strains 7 and 32 also had
very similar restriction endonuclease digest patterns to each other and had the
same antimicrobial resistance profile (Table 2), as did the plasmids from strains 9
252
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Table 5. Characteristics of plassmids positive for the dhfrl probe
Resistance profile
TP
TI, Te
TP, T, Ctm, Ap
TP, Su, Tc, Ap. SSm, Sp
TP. Sn. Te, Apl Sin, Sp
TP. Su, TC. Ap. Sin. Sp
T). Su. Tc, Ap. Sm. Sp
Tp. S., Ap. Sin, Sp
Tp). Su, Tc, Ap. Sin, ,S
Tp. Su, Tc, Ap, Sin, Sp
TP. KIn Tc. Ap Sin. Sp
Plasmid size (Kb)
40
60, 85
77, 2
48. 4
48. 4
94
57. 7. 4
35. 7. 4
57, 7, 4
77, 30. 2
84
Trhe largest plasInid (arried the *Ihfr in all cases.
Table 6. Plasmids positive for the dhfrlV probe in this stutdy
Plasinids
p)1K200)5 (10)
p)1K2007 (16)
pUK2012 (34)
p11K2013 (35)
pUK2014 (36)
pJ)K2019 (118)
pt'K2026 (179)
Resistance profile
Tp. Su, Tc. Sm, Ap
Tp. Su, Tc, Sm, Ap
Tp. Su. Te. Sm. Ap
Tp, Su, Teo Sm. Ap
Tp. Su. Tc, Sin. Ap
Tp. Su, Sin, Ap. Km
Tp? Su, Sin
Plasinid size (Kb)
65
65
65
65
65
52
77
Numbers in parentheses are the original donor strains.
and 60, harbouring the dhfr lb. Both of these plasmids were isolated from the same
village.
Many of the transconjugants harbouring the dhfrV were sensitive to
sulphamethoxazole (Table 3) which is usually associated with Tn2l and the
integrase system of this transposon [46]. Only 3 of those plasmids that did not
show hybridization with the tnpA probe were sulphamethoxazole resistant. Only
2 of the plasmids which gave positive hybridization with the tnpA gene did not
carry resistance to sulphamethoxazole (Table 3).
The remaining 11 of the transconjugants, that demonstrated high level
resistance to trimethoprim, all harboured the dhfrla gene (Table 5). All of these
plasmids showed positive hybridization with the probe for the Tn7 integrase ORF
(Table 5).
All the plasmids that were responsible for mediating low level resistance to
trimethoprim demonstrated positive hybridization with the probe for the dhfrIV
gene (Table 6). Five of these plasmids were identical in both their antibiotic
resistance and restriction endonuclease digest pattern although they were again
isolated from different areas.
Of those strains that did not transfer trimethoprim resistance, 27 were shown
to carry the dhfrla gene by colony blot and hybridization (Table 7). Only four
strains that did not transfer trimethoprim resistance hybridized with the probe for
the dhfrV (Table 8).
DoInor
185
188
111
6
26
29
208
217
219
167
163
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Table 7. Strains that demonstrated positive hybridization with the dhfrIa gene
probe but were not capable of transferring trimethoprim resistance
Resistance profile Strain number
Tp Su Ap Tc Cm Sm/Sp Hg Km 174
Tp Su Ap Tc Sm/Sp Hg Km 203
Tp Su Ap Tc Cm Sm/Sp 47, 54, 110, 112, 117, 141,
148, 152, 153, 161, 170, 193
Tp Su Ap Tc Cm Km 149
Tp Su Ap Cm Sm/Sp 195
Tp Su Ap Te Cm 173
Tp Ap Tc Sm/Sp 45
Tp Su Tc Sm/Sp 61, 139, 155, 172, 194, 201
Tp Su Sm/Sp 162, 171
Tp 136
Table 8. Strains that demonstrated positive hybridization with the dhfr V gene
probe but did not transfer trimethoprim resistance
Resistance profile Strain number
Tp Su Ap Tc Sm 23
Tp Su Ap Tc Cm Sm Hg 37, 56, 191
DISCUSSION
Trimethoprim resistant Gram-negative rods were encountered at very high
rates in the normal faecal flora in urban and rural populations in Tamil Nadu,
south India [13]. Thirty-six percent of this resistance was due to transferable
plasmid-mediated resistance to the drug. Along with resistance to trimethoprim,
a number of other resistance determinants were co-transferred. All the transferable
resistance determinants were shown to result from the presence of previously
described trimethoprim resistant DHFRs. In this survey, however, the type V
DHFR was marginally the most frequently isolated of the plasmid-mediated
DHFRs, accounting for a third of the transferable resistance. The type Ia DHFR
is usually found to be the most commonly isolated DHFR [27, 4]. In this case,
only 11 of the transconjugants were shown to harbour the dhfrla gene.
The epidemiology of the dhfrlb gene has not been well studied and its
prevalence is not known. The probe for the dhfrV gene hybridized, under
conditions of high stringency, with 5 plasmids (Table 4) that were later shown to
hybridize with the oligo-probe for the dhfr lb. This probe cannot therefore
differentiate between the dhfrV and dhfrlb and the use of this probe may mask the
true extent of the dhfr lb. The dhfrlb has been characterized in a transposon
Tn4132 that is similar to Tn7 [33]. In this study, however, the plasmids did not
hybridize with the Tn7 integrase-like ORF but did hybridize with the integrase
probe for Tn2l and the transposase of TN2 1. This may indicate the presence of the
dhfrlb on a Tn2l-like transposon having been integrated to this location as part
of a gene cassette, further work is underway in the characterization of these
elements.
The dhfrV gene was first characterized in strains from Sri Lanka [41] and the
region where these strains were collected is close to Sri Lanka. Other studies in
which the dhfrV has been frequently found have also shown some association with
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this part of Asia. In a study conducted in Sicily the type V DHFR was shown to
be the most frequently isolated of the DHFRs in an outbreak of trimethoprim
resistant Shigella sp. It was, however, thought that the strain had been introduced
in immigrants from Sri Lanka [47]. In a study conducted in Finland, 4 or 5 Shigella
carrying the dhfrV gene probably originated in Sri Lanka [48]. The DHFR type
Vr may have originated in this area or this region may represent a focus for this
resistance gene.
The dhfrIa gene was the most common trimethoprim resistance gene in those
strains that were not capable of transferring resistance. The movement of the
dhfrla gene onto the chromosome via the action of Tn7 has been noted on previous
occasions. This reflects the preferred insertion of Tn7 into the E. coli chromosome
at the specific insertion site attTn7 [26]. Here, as in other surveys, this has resulted
in an increasing identification of the dhfr Ia gene as part of the E. coli chromosome
[28, 50]. The dhfrla gene accounted for 53% of the identified trimethoprim
resistance mechanisms, and 36 % of all trimethoprim resistant isolates. The
stability conferred on the gene by insertion into the chromosomes has probably
resulted in the success of the dhfrla gene mediated by Tn7.
The dhfrV, encoded by Tn2l has not met with the same success, although the
Tn2l-like group of transposons is responsible for a wide range of different
resistance mechanisms [46]. The integron system associated with the Tn2l-group
of transposons has been responsible for the accumulation of resistance mechanisms
to sulphonamides [45], ,3-lactams [50], aminoglycosides [51], heavy metals [52]
and disinfectants [25] as well as the insertion of the dhfr genes encoding for the
DHFR types lIc, V [23], VII [25], X [32]. Recently the dhfrla has been found in
Tn2I inserted as a gene-cassette that has been shown to be associated with Tn7;
however, the integrase of Tn7 seems to have undergone a deletion that has
rendered it inoperative [29, 32].
All of the dhfrV genes identified in this study are associated with the integrase
ORF of Tn2I; however, 8 showed no positive hybridization with the probe for the
transposase of Tn2I. This indicates the insertion of the integron into the plasmid
without the presence of an intervening transposon, has had been demonstrated in
the case of the dhfrll of plasmid R388 [23]. Several of these plasmids also lack
resistance to the sulphonamides, that is usually found associated with the dhfrV
gene [29] and integron structures in general [46]. This indicates that sulpha-
methoxazole resistance has been deleted or is not being expressed. Further
investigation of the structures involved in the integration of the dhfrV gene will
need to be performed to confirm the genetic background of trimethoprim
resistance in these plasmids.
The type IV DHFR was identified in all plasmids which conferred low level
resistance to trimethoprim. Five of the transconjugants showed the presence of
the same 65 Kb plasmid mediating resistance to trimethoprim, sulpha-
methoxazole, tetracycline, ampicillin and streptomycin. The other two plasmids
were distinct from each other and this group. These plasmids all showed some
similarities in resistance profile when compared with those plasmids previously
characterized harbouring the dhfrIV gene (Table 6). The dhfrIV gene has not been
identified in other parts of the world. This may be as the result of: (1) the
mechanism is restricted to this part of India; (2) failure to detect the low level of
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resistance demonstrated by this mechanism under normal sensitivity testing
conditions; and (3) failure to detect transconjugants bearing the dhfrIV, again
because of the low level of resistance demonstrated when ISTA is used. However,
the unique induction mechanism of the DHFR type IV means that the actual MIC
may be much higher when the enzyme has been induced prior to the sensitivity
test [37].
The continued persistence of this resistance mechanism, despite the presence of
ostensibly more effective resistance mechanisms, the DHFR types Ia and V,
suggests some level of success for the dhfr gene for the type IN' in this region. The
evolution of this inducible DHFR may be a result of the conditions influencing
antibiotic resistance in this region, i.e. high use and 'self-dosing' with
antimicrobials available without prescription in any amount affordable to the
customer [13].
Thus high rates of resistance to trimethoprim in the normal gut flora of this
population are due to mechanisms previously identified in pathogenic strains.
Resistance is plasmid- and transposon-mediated and integron activity seems to be
associated with the dhfrV genes identified in the plasmids responsible for
trimethoprim resistance. High rates of resistance have been reported in Vellore in
S. fiexneri and S. shigae, 84% and 88 % resistance respectively, carrying
transferable resistance to trimethoprim [53]. The genes identified here are capable
of transfer to pathogenic strains and will constitute a reservoir of resistance which
may threaten the use of trimethoprim in this area, especially in the treatment of
shigellosis, typhoid and paratyphoid that are endemic in this region.
ACKNOWLED)GEMENT
We thank the WVellcome Trust for grant no. 34079/1.5 which funded this work.
REFERENCES
1. Burchall JJ, Hitchings GH. Inhibitor binding analysis of dihydrofolate reductases from
various species. AMol Pharmacol 1965; 1: 126--36.
2. Amves SGB, Smith ,JT. R-factor trimethoprimn resistance mechanism: an insusceptible
target site. Biochem Biophys Res Comin 1974: 58: 412-18.
3. Amyes SGB, Towner KJ. Trimethoprim resistance; epidemiology and molecular aspects. J
AMed AMicrobiol 1990; 31: 1-19.
4. Heikkilii E. Renkoneni OV, Sunila R. lurasmaa P, Huovinen P. The emergence and
mechaniisms of trimnethoprim resistance in Escherichia (oli isolated from out-patients in
Finland. J Antimicrob Chemother 1990: 25: 275-83.
5. Young H-K, AmnNes SGB. Trimethoprim resistance amonig urinary pathogens in south
India. J Antimicrob (hemother 1986; 23: 143 9.
6. t'rbina R. Prado V. Canelo E. Trimethopriin resistance in enterobacteria isolated in Chile.
.J Antimnicrob Chemother 1989: 23: 143 9.
7. Goldstein FWV, Papadopolou B, Acar JF. The changing patterin of trimethopriin resistance
in Paris, with a review of world wide experience. Rev Infect Dis; 8: 725-37.
8. Sol6rzano F. Leafios M, Guiscarf6 H. Resistancia antimnicrobiania actual de Salnmonella
typhi. Salmonella enteriditis y Shigella spp. Bol Med Hosp Infant AMexico 1987; 44: 448-55.
9. Murray BE. Alvarado T, Kim K-H, et al. Increasiing resistaince to trimethoprim-
sulphamethoxazole among isolates of Escherichia coli in developing countries. .J Infect Dis
1985: 152: 1107-13.
10. Shahid NS, Rahmani MIMI. Haider K. Banu H, Rahmian N. Changing patternl of resistant
Shiga bacillus (Shigella dysenteriae type I) anid Shige/la fiextneri in Bangladesh. .J Infect Dis
1985; 152: 1114-19.
Resistant dihydrofolate reductases 257
11. Jesudason MV, Joseph D, Koshi GU. Transferable resistance in Shigellae encountered in
Vellore (south India). Indian J Med Res 1989; 89: 297-9.
12. Frost JA. Rowe B, Vandepitte J. Acquisition of trimethoprim resistance in epidemic strains
of Shigella dystenteriae I from an epidemic in central Africa. J Hyg 1982; 94: 163-72.
13. Amyes SGB, Tait 8, Thomson CJ. et al. The incidence of antibiotic resistance in aerobic
faecal flora in south India. J Antimicrob Chemother 1992; 29: 415-25.
14. Shanahan PMA, W ylie BA, Adrian PV, Koornhof HJ, Thomson CJ, Amyes SGB. The
prevalence of antimicrobial resistance in human faecal flora in south Africa. Epidemiol
Infect 1993; 111: 221-8.
15. Shears P, Saliman G, Hart CA. Occurrence of multiple resistance and R-plasmids in
Enterobacteriaceae isolated from children in the Sudan. Epidemiol Infect 1988; 100: 73-81.
16. Lamikanra A, Ndep RB. Trimethoprim resistance in urinary tract pathogens in two
Nigerian hospitals. ,J Antimicrob C(hemother 1989; 23: 1t51-4.
17. Bonten M, Stobberingh E, Philips J, Houben A. High prevalence of antibiotic resistant
Escherichia coli in faecal samples in students in the south-east of the Netherlands. J
Antimicrob Chemother 1990; 26: 585-92.
18. Bonteii M, Stobberingh E, Philips J, Houben A. Antibiotic resistance of Escherichia coli in
faecal samples of healthy people in two different areas in an industrialized country.
Infection 1992; 20: 258-62.
19. Amnves SGB, Towner KJ. Young H-K. (lassification of dihydrofolate reductases conferring
trimethoprim resistance. J Med Microbiol 1992; 36: 1-3.
20. Singh KV, Reves R, Pickering LK. Murray BE. Identification by DNA sequence analysis
of a new plasmid-encoded trimethoprim resistance gene in faecal Escherichia coli isolates
from children in day care-centres. Ant,imicrob Agents Chemother 1992; 36: 1720-6.
21. Fliing AIE. Richards C. The nucleotide sequence of'the trimethoprim-resistant dihydrofolate
reductase gene harboured by Tn7. Nuc Acid Res 1983: 11: 5147-58.
22. Youing H-K, Amyes SUB. Characterization of a new transposon-mediated trimethoprim-
resistant dihvdrofolate reductase. Biochem Pharmacol 1985; 34: 4334-7.
23. Sundstr(im L, Radstr6im P, Swedberg U, Sk6ild 0. Site-specific recombination proinotes
linkage between trimethoprim and sulphonamide resistance genes. Sequence characteriza-
tion of dhfrV and sull and the recombination active locus of Tn2J. Mol Gen G(enet 1988:
213: 191-201.
24. W Wlie BA, Koornhof H.J. Nucleotide sequence of the dihydrofolate type VI. J AMed
Microbiol 1991: 35: 214-8.
25. Sundstr6im L, Swedberg GU Skiild 0. Characterization of transposon Tn5086, carrying the
site-specifically inserted gene dhfr VII mediated trimethoprim resistance. J Bacteriol 1993;
175: 1796-805.
26. Lichtenstein C. Brenner S. Unique insertioin site of Tn7 in the Escherichia coli chromosome.
Nature 1982; 297: 601-3.
27. Towner KJ, Carter (G1 Young H-K. Amnyes SUB. l)etection of novel trimethoprim
resistance determinants in the tUnited Kingdom using biotin-labelled DNA probes.
Epidemiol Infect 1991; 106: 63-70.
28. Hekkili E. Sundstr6im L, Skurnik Al, Huovineni P. Analyrsis and localization of the type I
trimethoprim resistance gene from Escherichia coli isolated in Finland. Antimicrob Agents
Chemother 1991: 35: 1,562--9.
29. Sundstr(im L, Skild 0. The dhfrl trimethoprim-resistance gene of Tn7 ean be fouind at
sp)e(ific sites in other genetic elements. Antimicrob Agents Chemother 1990; 34: 642-50.
30. Tietze E. Brevet J, Tschape H. Relationships amongst the streptothricin resistance
transp)osons Tn1825 and Tnl826 and the trimethoprim resistance transposon Tn7. Plasmnid
1987: 18: 246-9.
31. Sundstr6mn L, Roy PH. Sk(ild 0. Site-specific insertioni of three structural gene-cassettes
intranisposon Tn7. J Bacteriol 1991: 173: 3025-8.
32. Parsonis Y. Hall RAI, Stokes HW. A new trimethoprim resistance gene dhfrX in the In7
integroin of pD()O100. Antimicrob Agents Chemother 1991: 35: 2536-9.
33. Younig H-K. Qumsieh MIJ, AMclntosh MlL. Nucleotide se(quence and genetic analysis of the
type lb trimethoprim resistant, Tm4132-encoded dihydrofolate reductase. J Antimicrob
Cheinotlher. In press.
258 S. TAIT AND S. G. B. AMYES
34. Young H-K, Amyes SGB. A new mechanism of plasmid-mediated trimethoprim resistance.
Characterization of an inducible dihydrofolate reductase. J Biol Chem 1986; 261: 2503-5.
35. Young H-K, Jesudason MV, Koshi G, Amyes SGB. Unusual expression of new low-level
trimethoprim-resistance plasmids. J Clin Microbiol 1986; 24: 61-4.
36. Thomson C(J, Young H-K, Amyes SGB. The role of thymine starvation in the expression
of the type IV plasmid-encoded trimethoprim-resistant dihydrofolate reductase. J Med
Microbiol 1993; 32: 250-5.
37. Tait S. Trimethoprim resistance in normal flora from India [Thesis]. Edinburgh, UK:
University of Edinburgh. 1993.
38. Amyes SGB, Gould I. Trimethoprim resistance plasmids. Annales de Microbiologie 1984;
135B: 177-86.
39. Takahashi 5, Nagano Y. Rapid procedure for the isolation of plasmid DNA and application
to epidemiological analysis. J Clin Microbiol 1984; 20: 608-13.
40. Southern E. Detection of specific sequences among DNA fragments separated by gel
electrophoresis. J Mol Biol 1976; 98: 503-17.
41. Sundstrim L, Vinayagamoorthy T, Sk6ld 0. Novel type of plasmid-borne trimethoprim
resistance. Antimicrob Agents Chemother 1987; 31: 60-6.
42. Mayer KH, Fling ME, Hopkins JD, O'Brien JF. Trimethoprim resistance in multiple
genera of Enterobacteriaceae at a US hospital: spread of the type II dihydrofolate
reductase by a single plasmid. J Infect Dis 1985; 151: 783-9.
43. Towner KJ, Young H-K, Amyes SGB. Biotinylated probes for trimethoprim-resistant
dihydrofolate reductases type IV' and V. J Antimicrob Chemother 1988; 22: 285-91.
44. Towner KJ, Carter GI. Cloning of the type VII trimethoprim-resistant dihydrofolate
reductase and identification of a specific DNA probe. FEMS Microbiol Letts 1990; 58:
19-22.
45. Sambrook J, Fritsch EF, Maniatis T. AMolecular cloning: A laboratory manual, 2nd ed. Cold
Spring Harbor, NY: Cold Spring Harbor Laboratory, 1984.
46. Bissonnete L, Roy PH. Characterization of InO of Pseudomonas aeruginosa plasmid pSV1
an ancestor of integrons of multiresistance plasmids and transposons of gram-negative
bacteria. J Bacteriol 1992; 174: 1228-57.
47. Agodi A, Jones C, Threfall EJ, D'Angelo M, Marranzano M. Molecular characterization of
trimethoprim resistance in Shigella sonnei in Sicily. Epidemiol Infect 1990; 105: 29-40.
48. Hekkila E, Siitonen A, Jahkla M, Fling ME, Sundstr6m L, Huovinen P. Increase of
trimethoprim resistance among Shigella species, 1975-1988: analysis of resistance
mechanisms. J Infect Dis; 161: 1242-8.
49. Steen R, Sk6ld 0. Plasmid-borne or chromosomally mediated resistance by Tn7 is the most
common response to the ubiquitous use of trimethoprim. Antimicrob Agent Chemother
1985; 27: 933-7.
50. Lafond M, Couture F, Vezina G, Lavesque RC. Evolutionary aspects in multiresistance f-
lactamase transposons. J Bacteriol 1989; 171: 6423-9.
51. Wohileben W, Arnold W, Bissonnette L, et al. On the evolution of the Tn2l-like
transposons: Sequence analysis of the gene (aac1) for the gentamicin acetyltransferase-3-1
[AAC(3)-1] another member of the Tn2l-based expression cassette. Mol Gen Genet 1989;
217: 202-8.
52. Brown NI, Winnie JN, Seiff M, Silver S. The nucleotide sequence of the mercuric resistance
operons of plasmid R100 and transposon Tn501, further evidence for mer genes which
enhance the mercuric ion detoxification system. Mol Gen Genet 1986; 202: 143-51.
53. Jesudason MV, Joseph G, Koshi G. Transferable trimethoprim resistance in Shigellae
encountered in Vellore south India. Indian J Med Res 1989; 89: 297-9.
